Dr. Charles Armistead Thompson, MD

Dr. Thompson practices at Lung And Critical Care Specialists Of Anderson in Spartanburg, South Carolina.

Dr. Thompson's NPI, 1851394597, was assigned on May 26, 2005. Dr. Thompson graduated from Baylor College of Medicine in 1985. Dr. Thompson holds South Carolina license 17521.

Dr. Thompson's primary practice is Lung and Critical Care Specialists of Anderson, at 151 Harold Fleming Ct, Spartanburg, SC 29303. The practice phone is (864) 540-8025.

Dr. Thompson's primary practice is Lung And Critical Care Specialists Of Anderson in Spartanburg, South Carolina. Dr. Thompson is also affiliated with AnMed Medical Center. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Thompson to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thompson practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Thompson's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Thompson is licensed in South Carolina.

CMS data shows 2,016 Medicare services from Dr. Thompson across 9 procedure codes in 2024, for 393 Medicare patients. Medicare paid $128,088 for them.

CMS counts 393 Medicare patients who saw Dr. Thompson in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thompson's median patient age at 70, with 59% women.

In 2024, Dr. Thompson wrote 9,216 Medicare Part D claims for 713 patients. 72% of them were for generic drugs. CMS names the drug for 8,725 of them, across 115 drugs with 11 or more claims each, at $5,142,575 in total drug cost. In 2023, CMS named 7,836 claims across 112 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Thompson for performance year 2024, reported individually. Dr. Thompson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thompson as offering telehealth.

Dmand AI links Dr. Thompson to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, COVID-19 and Pneumonia, Viral. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Thompson that name 2 trials.

CMS Open Payments shows 1,226 general payments to Dr. Thompson from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,858. It also lists 11 research payments totaling $134,565 from 2016 to 2023, naming 2 clinical trials.

Dr. Thompson graduated from Baylor College of Medicine in 1985.